Toyond Inc

BioCorRx Pharmaceuticals Inc. is a public company incorporated in 2008, specializing in pharmaceutical solutions and traded on the OTCQB under the stock symbol BICX. The company became publicly listed in 2011 through a reverse merger and is headquartered in Anaheim, California. With a fiscal year ending on December 31st, BioCorRx is supported by a team of independent auditors and legal counsel, ensuring robust governance and financial practices. The company is actively engaged in creating partnerships and opportunities in the pharmaceutical market, focusing on innovative treatments. Generated from the website

Headquartered in Orange, Calif., NuCare Pharmaceuticals provides prepackaged pharmaceutical products for physician offices, hospitals and pharmacies. It is licensed by Food and Drug Administration. The company operates an online allergy center that offers information about identifying and treating several allergic conditions. NuCare Pharmaceuticals additionally publishes articles and researches in areas of health care. It provides a range of tablets, capsules, syringes and injections. The company offers medical supplies for cough and cold, cardiac problems, hormonal disorders, central nervous system and analgesics. NuCare Pharmaceuticals features emergency rooms and urgent care centers.

Quotient Pharmaceuticals Manufacturing is an innovative biopharmaceutical company based in Anaheim, CA, dedicated to the development, commercial manufacture, and marketing of proprietary technologies in the natural human antibody field. The company focuses on creating polyclonal human antibodies sourced from specially stimulated donors, aiming to redefine the standard of care for significant healthcare challenges. With a strong emphasis on scientific and commercial success, Quotient's technology platform offers a reliable use of human antibodies to provide safe treatment options. Their initial product line targets critical areas such as allergy and allergic asthma, inflammatory diseases and autoimmune disorders, as well as neuropathic pain and fibromyalgia, addressing urgent unmet medical needs in large biopharmaceutical markets. Generated from the website